Computer-Aided Drug Discovery Market Size to Grow US$ 10.44 Billion By 2032

The global computer-aided drug discovery market size was approximate at US$ 3.36 billion in 2022 and is anticipated to grow US$ 10.44 billion by 2032, registering a compound annual growth rate of 12% from 2023 to 2032.

The computer-aided drug discovery market report covering various industry elements and growth trends helpful for predicting the market’s future.

The study provides a strong base for the computer-aided drug discovery market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2032.

This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2023 g0066ztr to 2032. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the computer-aided drug discovery report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the computer-aided drug discovery market have been studied and analysed across many developments.

Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2965

Computer-Aided Drug Discovery Market Report Scope

Also read: Prostate Cancer Market Size to Grow US$ 28.37 Billion By 2032

Research Approach

The comprehensive report on the global computer-aided drug discovery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global computer-aided drug discovery market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Key Players

• Albany Molecular Research Inc. (AMRI)
• BOCSCI Inc.
• AstraZeneca
• Bioduro-Sundia
• Schrödinger, Inc.
• Bayer AG
• Aragen Life Sciences Pvt. Ltd.
• Charles River Laboratories
• Aris Pharmaceuticals
• Albany Molecular Research Inc.

Computer-Aided Drug Discovery Market Segmentations

By Type

• Structure-based Drug Design
• Ligand-based Drug Design
• Sequence-based Approaches

By Therapeutic Area

• Oncology
• Neurology
• Cardiovascular diseases
• Respiratory diseases
• Diabetes

By End User

• Pharmaceuticals companies
• Biotechnology companies
• Research Laboratories

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Computer-Aided Drug Discovery Market 

5.1. COVID-19 Landscape: Computer-Aided Drug Discovery Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Computer-Aided Drug Discovery Market, By Type

8.1. Computer-Aided Drug Discovery Market Revenue and Volume, by Type, 2023-2032

8.1.1 Structure-based Drug Design

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Ligand-based Drug Design

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Sequence-based Approaches

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Computer-Aided Drug Discovery Market, By Therapeutic Area

9.1. Computer-Aided Drug Discovery Market Revenue and Volume, by Therapeutic Area, 2023-2032

9.1.1. Oncology

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Neurology

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Cardiovascular diseases

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

9.1.4. Respiratory diseases

9.1.4.1. Market Revenue and Volume Forecast (2020-2032)

9.1.5. Diabetes

9.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Computer-Aided Drug Discovery Market, By End User

10.1. Computer-Aided Drug Discovery Market Revenue and Volume, by March, 2023-2032

10.1.1. Pharmaceuticals companies

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Biotechnology companies

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Research Laboratories

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Computer-Aided Drug Discovery Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.1.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.1.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.1.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.2.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.2.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.2.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.6.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.2.6.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.7.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.2.7.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.3.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.3.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.3.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.6.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.3.6.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.7.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.3.7.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.4.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.4.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.6.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.4.6.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.7.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.4.7.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.4.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.5.4.3. Market Revenue and Volume Forecast, by End User(2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.5.2. Market Revenue and Volume Forecast, by Therapeutic Area (2020-2032)

11.5.5.3. Market Revenue and Volume Forecast, by End User(2020-2032)

Chapter 12. Company Profiles

12.1. Albany Molecular Research Inc. (AMRI)

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. BOCSCI Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. AstraZeneca

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Bioduro-Sundia

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Schrödinger, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Bayer AG

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Aragen Life Sciences Pvt. Ltd.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Charles River Laboratories

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Aris Pharmaceuticals

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Albany Molecular Research Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global computer-aided drug discovery market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for computer-aided drug discovery are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com